CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. It also provides technology transfer and technical consulting services of biotechnology. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.
Frequently asked questions
What sector does CSPC Innovation Pharmaceutical Co Ltd Class A (300765) operate in?
CSPC Innovation Pharmaceutical Co Ltd Class A belongs to the Consumer Staples sector and operates in the Packaged Foods industry.
What is CSPC Innovation Pharmaceutical Co Ltd Class A (300765) current stock price?
As of the latest data, CSPC Innovation Pharmaceutical Co Ltd Class A stock price is CN¥41.28, with a previous close of CN¥42.75. CSPC Innovation Pharmaceutical Co Ltd Class A lost -CN¥1.47 in the last trading session, representing a -3.44% loss.
What is CSPC Innovation Pharmaceutical Co Ltd Class A (300765) current market capitalization?
CSPC Innovation Pharmaceutical Co Ltd Class A market cap is approximately 57.98 billion.
What is CSPC Innovation Pharmaceutical Co Ltd Class A (300765) Earnings Per Share (EPS)?
The trailing EPS is -CN¥0.22, and the forward EPS is CN¥0.81.
Does CSPC Innovation Pharmaceutical Co Ltd Class A (300765) pay dividends?
No. CSPC Innovation Pharmaceutical Co Ltd Class A does not pay a dividend.
What is CSPC Innovation Pharmaceutical Co Ltd Class A (300765) beta (volatility) score?
CSPC Innovation Pharmaceutical Co Ltd Class A has a beta of 0.101, indicating lower volatility than the overall market.
